Safety and immunogenicity of a recombinant double-mutant heat-labile toxin derived from enterotoxigenic Escherichia coli in healthy Bangladeshi adults delivered by three different routes
Authors
Wilbur H. Chen (ORCID: https://orcid.org/0000-0001-7741-5536)
Marcelo B. Sztein (ORCID: https://orcid.org/0000-0001-8282-860X)
A. Louis Bourgeois (ORCID: https://orcid.org/0000-0001-8952-5302)
Karen L. Kotloff (ORCID: https://orcid.org/0000-0003-1808-6431)
International Centre for Diarrhoeal Disease Research, Bangladesh
National Institute of Allergy and Infectious Diseases
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Safety and immunogenicity of a recombinant double-mutant heat-labile toxin derived from enterotoxigenic Escherichia coli in healthy Bangladeshi adults delivered by three different routes
Wilbur H. Chen, Marcelo B. Sztein, A. Louis Bourgeois, Karen L. Kotloff et al.
Citations
3 citations
Journal
Frontiers in Bacteriology
Topics
Escherichia coli research studies
Field-Weighted Citation Impact (FWCI)
5.39
article
Safety and immunogenicity of a recombinant double-mutant heat-labile toxin derived from enterotoxigenic Escherichia coli in healthy Bangladeshi adults delivered by three different routes
Wilbur H. Chen, Marcelo B. Sztein, A. Louis Bourgeois, Karen L. Kotloff, Aklima Akter, Mohammad Kamruzzaman, Al Hakim, Taufiqur Rahman Bhuiyan, Jessica Butts, Nasrin Parvin, N.A. Harun, Nicole Maier, Rezwanul Wahid, Farhana Khanam, Shahinur Haque, Polash Chandra Karmakar, Salima Raiyan Basher, Jessica A. White, Mohiul Islam Chowdhury, Marcela F. Pasetti, Tasnuva Ahmed, Al Amin, Shahida Baqar, Kay M Tomashek, Pinki Dash
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in BacteriologyVol. 4
Institutions
University of Maryland, Baltimore (US), National Institutes of Health (US), Program for Appropriate Technology in Health (US), International Centre for Diarrhoeal Disease Research (BD), Emmes (United States) (US), National Institute of Allergy and Infectious Diseases (US)
Funders
Bill and Melinda Gates Foundation, International Centre for Diarrhoeal Disease Research, Bangladesh, National Institute of Allergy and Infectious Diseases